Literature DB >> 24286250

Endoproteolytic processing of the mammalian prion glycoprotein family.

Charles E Mays1, Janaky Coomaraswamy, Joel C Watts, Jing Yang, Kerry W S Ko, Bob Strome, Robert C C Mercer, Serene L Wohlgemuth, Gerold Schmitt-Ulms, David Westaway.   

Abstract

Cellular prion protein (PrP(C)) misfolds to form infectivity-associated scrapie prion protein and generates C-terminal fragments C1 and C2 in healthy and prion-infected animals. C1 cleavage occurs N-terminally of PrP(C)'s hydrophobic domain, whereas the larger C2 fragment is generated by cleavage at the end of the octarepeat region. As the PrP-like proteins Doppel and Shadoo (Sho) have been reported to inhabit similar membrane environments as PrP(C), we investigated endoproteolysis by using a panel of mutant alleles. Doppel undergoes efficient in vivo cleavage at a C1 site mapped to the start of the globular domain, which is a structurally similar cleavage site to that in PrP(C). Sho is processed to C1 and C2 fragments, and proved refractory to mutagenesis to inactivate C1 cleavage. As a reciprocal product of C1 cleavage, Sho also engenders a metabolically stable N1 fragment with a C-terminus after its hydrophobic domain, an observation that may account for N1's association with membrane and/or cellular fractions in vitro and in vivo. Our data indicate that glycosylation status and yet to be identified proteases modulate internal C1 and C2 proteolysis events within the mammalian prion protein family.
© 2013 FEBS.

Entities:  

Keywords:  ADAM; Doppel; Shadoo; endoproteolysis; prion protein

Mesh:

Substances:

Year:  2013        PMID: 24286250     DOI: 10.1111/febs.12654

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

Review 2.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

3.  Functional genomics screen identifies proteostasis targets that modulate prion protein (PrP) stability.

Authors:  Jennifer Abrams; Taylor Arhar; Sue Ann Mok; Isabelle R Taylor; Martin Kampmann; Jason E Gestwicki
Journal:  Cell Stress Chaperones       Date:  2021-02-05       Impact factor: 3.827

Review 4.  Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP.

Authors:  Akikazu Sakudo; Takashi Onodera
Journal:  Front Cell Dev Biol       Date:  2015-01-15

5.  Neuroprotective properties of the PrP-like Shadoo glycoprotein assessed in the middle cerebral artery occlusion model of ischemia.

Authors:  Nathalie Daude; Hristina Gapeshina; Bin Dong; Ian Winship; David Westaway
Journal:  Prion       Date:  2015       Impact factor: 3.931

6.  Regulation of sub-compartmental targeting and folding properties of the Prion-like protein Shadoo.

Authors:  Anna Pepe; Rosario Avolio; Danilo Swann Matassa; Franca Esposito; Lucio Nitsch; Chiara Zurzolo; Simona Paladino; Daniela Sarnataro
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

7.  Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.

Authors:  Luise Linsenmeier; Behnam Mohammadi; Sebastian Wetzel; Berta Puig; Walker S Jackson; Alexander Hartmann; Keiji Uchiyama; Suehiro Sakaguchi; Kristina Endres; Jörg Tatzelt; Paul Saftig; Markus Glatzel; Hermann C Altmeppen
Journal:  Mol Neurodegener       Date:  2018-04-06       Impact factor: 14.195

8.  Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.

Authors:  Sarah Ulbrich; Petra Janning; Ralf Seidel; Jakob Matschke; Anika Gonsberg; Sebastian Jung; Markus Glatzel; Martin Engelhard; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

Review 9.  Cellular and Molecular Mechanisms of Prion Disease.

Authors:  Christina J Sigurdson; Jason C Bartz; Markus Glatzel
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 32.350

Review 10.  The Cellular Prion Protein: A Player in Immunological Quiescence.

Authors:  Maren K Bakkebø; Sophie Mouillet-Richard; Arild Espenes; Wilfred Goldmann; Jörg Tatzelt; Michael A Tranulis
Journal:  Front Immunol       Date:  2015-09-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.